In lung cancer, tumor buds display decreased levels of membranous β-catenin [62], while in CRC and oral squamous cell carcinomas they display reduced levels of miR-200 family [115,116] which are strong inhibitors of ZEB1/2 [117,118,119]. This evidence concerns the gene ZEB1 and oral cavity squamous cell carcinoma.